JULIA PARKHURST: Open Payments
NPI 1427267509 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,244 in 101 payments from 15 companies in 2025. Trend: 2023 $1,991 · 2024 $1,881 · 2025 $2,244
Food & beverage: $1,986Education: $173Consulting: $85
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $438 |
| Regeneron Healthcare Solutions, Inc. | 10 | $380 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $314 |
| AstraZeneca Pharmaceuticals LP | 11 | $224 |
| GlaxoSmithKline, LLC. | 16 | $188 |
| Grifols USA, LLC | 8 | $151 |
| Amgen Inc. | 8 | $138 |
| CSL Behring | 4 | $101 |
| ADMA BioManufacturing LLC | 5 | $85 |
| BioCryst US Sales Co., LLC | 2 | $65 |
Products named: DUPIXENT, NEFFY, TEZSPIRE, Xembify, NUCALA, Hizentra, AIRSUPRA, FASENRA.
Industry payments across NC — which companies pay providers there.
